These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30108004)

  • 21. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
    Jalali R; Mallick I; Dutta D; Goswami S; Gupta T; Munshi A; Deshpande D; Sarin R
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):974-9. PubMed ID: 19864079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phantosmia during proton radiation and differences in frequency of phantosmia rates based on proton craniospinal irradiation technique for pediatric brain tumor patients.
    Ioakeim-Ioannidou M; Daartz J; Erfani P; Urell T; Lalonde A; Berv J; Leahy S; Fullerton B; Bolton R; Yock T; Tarbell N; Yeap B; MacDonald SM
    Pediatr Blood Cancer; 2024 May; 71(5):e30927. PubMed ID: 38421306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults.
    Hashimoto T; Shimizu S; Takao S; Terasaka S; Iguchi A; Kobayashi H; Mori T; Yoshimura T; Matsuo Y; Tamura M; Matsuura T; Ito YM; Onimaru R; Shirato H
    J Radiat Res; 2019 Jul; 60(4):527-537. PubMed ID: 31111946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Proton Center Closure on Pediatric Case Volume and Resident Education at an Academic Cancer Center.
    Galle JO; Long DE; Lautenschlaeger T; Zellars RC; Watson GA; Ellsworth SG
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):710-718. PubMed ID: 29413283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors.
    Eaton BR; Yock T
    Cancer J; 2014; 20(6):403-8. PubMed ID: 25415686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With Proton Therapy for Brain and Skull Base Tumors.
    Hall MD; Bradley JA; Rotondo RL; Hanel R; Shah C; Morris CG; Aldana PR; Indelicato DJ
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):854-859. PubMed ID: 29730064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy.
    Ventura LM; Grieco JA; Evans CL; Kuhlthau KA; MacDonald SM; Tarbell NJ; Yock TI; Pulsifer MB
    J Neurooncol; 2018 Mar; 137(1):119-126. PubMed ID: 29214403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment age and neurocognitive outcomes following proton beam radiotherapy for pediatric low- and intermediate-grade gliomas.
    Heitzer AM; Kahalley LS; Minard CG; Stafford C; Grosshans DR; Okcu MF; Raghubar KP; Gragert M; McCurdy M; Warren EH; Gomez J; Ris MD; Paulino AC; Chintagumpala M
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29096. PubMed ID: 34019329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches.
    Moxon-Emre I; Dahl C; Ramaswamy V; Bartels U; Tabori U; Huang A; Cushing SL; Papaioannou V; Laperriere N; Bouffet E; Mabbott DJ
    Cancer Med; 2021 Oct; 10(20):7111-7125. PubMed ID: 34480430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors.
    Song S; Park HJ; Yoon JH; Kim DW; Park J; Shin D; Shin SH; Kang HJ; Kim SK; Phi JH; Kim JY
    Acta Oncol; 2014 Sep; 53(9):1158-64. PubMed ID: 24913151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal Irradiation.
    Song L; Wang S; Fang T; Qiu X; Wang X; Zhou X; Morse MA; Hobeika A; Wu W; Yang H; Ren J; Lyerly HK
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):479-490. PubMed ID: 33974888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors.
    Brown AL; Sok P; Raghubar KP; Lupo PJ; Richard MA; Morrison AC; Yang JJ; Stewart CF; Okcu MF; Chintagumpala MM; Gajjar A; Kahalley LS; Conklin H; Scheurer ME
    Neuro Oncol; 2023 Sep; 25(9):1698-1708. PubMed ID: 37038335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy.
    Child AE; Warren EA; Grosshans DR; Paulino AC; Okcu MF; Ris MD; Mahajan A; Orobio J; Cirino PT; Minard CG; Viana AG; Bick J; Woods SP; Chintagumpala M; Kahalley LS
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29125. PubMed ID: 34114294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes.
    Grill J; Renaux VK; Bulteau C; Viguier D; Levy-Piebois C; Sainte-Rose C; Dellatolas G; Raquin MA; Jambaqué I; Kalifa C
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):137-45. PubMed ID: 10477017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.
    Zhang R; Howell RM; Giebeler A; Taddei PJ; Mahajan A; Newhauser WD
    Phys Med Biol; 2013 Feb; 58(4):807-23. PubMed ID: 23322160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
    Ho ESQ; Barrett SA; Mullaney LM
    Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
    Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
    Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.